<DOC>
	<DOCNO>NCT02596867</DOCNO>
	<brief_summary>This trial Phase II study use `` window-of-opportunity '' design treatment-free window breast cancer diagnosis surgical tumor resection use study biological effect beta blocker propranolol .</brief_summary>
	<brief_title>Neoadjuvant Propanolol Breast Cancer</brief_title>
	<detailed_description>- Patients recruit Garbar Breast Care Center University Medical Center follow diagnosis invasive breast cancer breast biopsy . - The sympatholytic nonselective beta blocker propranolol administer participant non-randomized manner equal dose 1.5 mg/kg/day . - Following surgical resection tumor , primary endpoint study quantify compare proliferative index tumor propranolol administration ( quantified use initial tumor biopsy ) 3 week propranolol ( quantified use surgically resect tumor ) . - Additional molecular analysis evaluation safety toxicity also perform good understand effect treatment breast cancer patient adherence drug .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>Ages 18 65 diagnosis stage IIII breast cancer , confirm core biopsy Planning undergo definitive surgery include mastectomy breast conserving surgery Systolic blood pressure must &gt; 100 mmHg 140 mmHg and/or diastolic &gt; 60 mmHg 95 mmHg . normal baseline EKG Exclusion criterion : Pregnancy ; potential subject female bearing age complete pregnancy test screening ensure pregnant . Potential patient postmenopausal must confirm one year without menstrual cycle . Free major medical illness include : Uncontrolled Diabetes ( HbA1c â‰¤ 8 previously test ) Uncontrolled hypertension : BP &gt; systolic 140/ diastolic &gt; 95 Cardiac disease ( history cardiac valve disease , coronary artery disease , congestive heart failure , AV block , peripheral vascular disease , cardiac arrhythmia/bradycardia ) exception diagnose cancer . Histories asthma , bronchospastic disease , obstructive pulmonary disease Previously diagnose thyrotoxicosis Severe allergic reaction medication include beta blocker family Previously currently treat beta adrenergic receptor antagonist Patients locally advance inflammatory breast cancer amenable surgical resection Patients take following medication exclude : Drugs categorize digitalis glycoside , betablockers calcium channel blocker , ACE inhibitor alpha blocker Amiodarone Cimetidine Ciprofloxacin Delavudin Dobutamine Ethanol Fluconazole Fluoxetine Fluvoxamine Haloperidol Imipramine Isoniazid Isoproterenol Luvoxamine Paroxetine Phenytoin Phenobarbital . Propafenone . Quinidine Reserpine Rifampin Ritonavir Rizatriptan . Tenioposide Theophylline Thyroxine Tolbutamide . Warfarin Zileuton Zolmitriptan</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>B adrenergic pathway</keyword>
	<keyword>B Blocker</keyword>
</DOC>